Profit

New drug pricing policy to boost profit of pharma firms: Kewal Handa

PUBLISHED ON: September 28, 2012 | Duration: 6 min, 01 sec

  
loading..
While congratulating the government on moving away from a cost plus model of drug pricing, Kewal Handa, Industry Expert, & Former MD, Pfizer Ltd also says that pharma companies will see a very large impact on profitability because of the new drug pricing norms.
ALSO WATCH
Pfizer Seeks Covid Vaccine Authorisation For 12-15 Year Olds In US

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com